Skip to main content
SpringerLink
Log in

Age-Related Macular Degeneration: The Challenges

  • Chapter
  • First Online:
Gene- and Cell-Based Treatment Strategies for the Eye

Part of the book series: Essentials in Ophthalmology ((ESSENTIALS))

  • 892 Accesses

Abstract

The following three chapters deal with the development of treatments for age-related macular degeneration (AMD or ARMD) and related conditions. Here we present a description of these conditions that best reflects the understanding of these diseases by the authors of these chapters.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  • Age-Related Eye Disease Study Research G (2001) A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 119(10):1417–1436

    Article  Google Scholar 

  • Age-Related Eye Disease Study 2 Research G (2013) Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA 309(19):2005–2015. doi:10.1001/jama.2013.4997

  • Ambati J, Fowler BJ (2012) Mechanisms of age-related macular degeneration. Neuron 75(1):26–39. doi:10.1016/j.neuron.2012.06.018

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Anderson DH, Radeke MJ, Gallo NB, Chapin EA, Johnson PT, Curletti CR, Hancox LS, Hu J, Ebright JN, Malek G, Hauser MA, Rickman CB, Bok D, Hageman GS, Johnson LV (2010) The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited. Prog Retin Eye Res 29(2):95–9112

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Coleman DJ, Silverman RH, Rondeau MJ, Lloyd HO, Khanifar AA, Chan RV (2013) Age-related macular degeneration: choroidal ischaemia? Br J Ophthalmol 97(8):1020–1023. doi:10.1136/bjophthalmol-2013-303143

    Article  PubMed Central  PubMed  Google Scholar 

  • Damico FM, Gasparin F, Scolari MR, Pedral LS, Takahashi BS (2012) New approaches and potential treatments for dry age-related macular degeneration. Arq Bras Oftalmol 75(1):71–76

    PubMed  Google Scholar 

  • Dawson DW, Volpert OV, Gillis P, Crawford SE, Xu H, Benedict W, Bouck NP (1999) Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 285(5425):245–248

    Article  CAS  PubMed  Google Scholar 

  • Friedman DS, O’Colmain BJ, Munoz B, Tomany SC, McCarty C, de Jong PT, Nemesure B, Mitchell P, Kempen J (2004a) Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 122(4):564–572. doi:10.1001/archopht.122.4.564

    Article  PubMed  Google Scholar 

  • Friedman DS, O’Colmain BJ, Munoz B, Tomany SC, McCarty C, de Jong PT, Nemesure B, Mitchell P, Kempen J, Eye Diseases Prevalence Research G (2004b) Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 122(4):564–572. doi:10.1001/archopht.122.4.564

    Article  PubMed  Google Scholar 

  • Gorin MB (2012) Genetic insights into age-related macular degeneration: controversies addressing risk, causality, and therapeutics. Mol Aspects Med 33(4):467–486. http://dx.doi.org/10.1016/j.mam.2012.04.004

  • Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, Hardisty LI, Hageman JL, Stockman HA, Borchardt JD, Gehrs KM, Smith RJ, Silvestri G, Russell SR, Klaver CC, Barbazetto I, Chang S, Yannuzzi LA, Barile GR, Merriam JC, Smith RT, Olsh AK, Bergeron J, Zernant J, Merriam JE, Gold B, Dean M, Allikmets R (2005) A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A 102(20):7227–7232. doi:10.1073/pnas.0501536102

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Kaiser PK (2006) Antivascular endothelial growth factor agents and their development: therapeutic implications in ocular diseases. Am J Ophthalmol 142(4):660–668. doi:10.1016/j.ajo.2006.05.061

    Article  CAS  PubMed  Google Scholar 

  • Kwak N, Okamoto N, Wood JM, Campochiaro PA (2000) VEGF is major stimulator in model of choroidal neovascularization. Invest Ophthalmol Vis Sci 41(10):3158–3164

    CAS  PubMed  Google Scholar 

  • Marx J (2006) Genetics – a clearer view of macular degeneration. Science 311(5768):1704–1705. doi:10.1126/science.311.5768.1704

    Article  CAS  PubMed  Google Scholar 

  • Mitchell P, Smith W, Attebo K, Wang JJ (1995) Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology 102(10):1450–1460

    Article  CAS  PubMed  Google Scholar 

  • Mousa SA, Mousa SS (2010) Current status of vascular endothelial growth factor inhibition in age-related macular degeneration. BioDrugs 24(3):183–194. doi:10.2165/11318550-000000000-00000

    Article  CAS  PubMed  Google Scholar 

  • Ratnapriya R, Chew EY (2013) Age-related macular degeneration-clinical review and genetics update. Clin Genet 84(2):160–166. doi:10.1111/cge.12206

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Raychaudhuri S, Iartchouk O, Chin K, Tan PL, Tai AK, Ripke S, Gowrisankar S, Vemuri S, Montgomery K, Yu Y, Reynolds R, Zack DJ, Campochiaro B, Campochiaro P, Katsanis N, Daly MJ, Seddon JM (2011) A rare penetrant mutation in CFH confers high risk of age-related macular degeneration. Nat Genet 43(12):1232–U1291. doi:10.1038/Ng.976

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Shen JK, Dong A, Hackett SF, Bell WR, Green WR, Campochiaro PA (2007) Oxidative damage in age-related macular degeneration. Histol Histopathol 22(12):1301–1308

    CAS  PubMed  Google Scholar 

  • Steinbrook R (2006) The price of sight–ranibizumab, bevacizumab, and the treatment of macular degeneration. N Engl J Med 355(14):1409–1412. doi:10.1056/NEJMp068185

    Article  CAS  PubMed  Google Scholar 

  • Stellmach V, Crawford SE, Zhou W, Bouck N (2001) Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor. Proc Natl Acad Sci U S A 98(5):2593–2597. doi:10.1073/pnas.031252398

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Zarbin MA (2004) Current concepts in the pathogenesis of age-related macular degeneration. Arch Ophthalmol 122(4):598–614

    Article  PubMed  Google Scholar 

  • Zhou J, Jang YP, Kim SR, Sparrow JR (2006) Complement activation by photooxidation products of A2E, a lipofuscin constituent of the retinal pigment epithelium. Proc Natl Acad Sci U S A 103(44):16182–16187

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Molecular Ophthalmology, Centre for Ophthalmology and Visual Sciences, The University of Western Australia, Crawley, WA, Australia

    Elizabeth P. Rakoczy PhD

  2. Department of Ophthalmology and Visual Sciences, University of Utah School of Medicine, John A. Moran Eye Center, University of Utah Health Sciences Center, Salt Lake City, UT, USA

    Cecinio C. Ronquillo Jr. PhD & Samuel F. Passi BA

  3. Department of Ophthalmology, University of Utah, Salt Lake City, UT, USA

    Balamurali K. Ambati MD, PhD, MBA

  4. Department of Ophthalmology, University of California, Los Angeles, CA, USA

    Aaron Nagiel MD, PhD

  5. Advanced Cell Technology, Marlborough, Massachusetts, USA

    Robert Lanza MD

  6. Retina Division, Jules Stein Eye Institute, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA

    Steven D. Schwartz MD

Authors
  1. Elizabeth P. Rakoczy PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cecinio C. Ronquillo Jr. PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Samuel F. Passi BA
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Balamurali K. Ambati MD, PhD, MBA
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Aaron Nagiel MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Robert Lanza MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Steven D. Schwartz MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Elizabeth P. Rakoczy PhD .

Editor information

Editors and Affiliations

  1. Department of Molecular Ophthalmology, Centre for Ophthalmology and Visual Sciences, The University of Western Australia, Crawley, West Australia, Australia

    Elizabeth P. Rakoczy

Ethics declarations

E.P. Rakoczy, C.C. Ronquillo, S.F. Passi, B.K. Ambati, Aaron Nagiel, Robert Lanza, and Steven D. Schwartz declare that they have no conflict of interest.

No human or animal studies were carried out for this chapter.

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Rakoczy, E.P. et al. (2015). Age-Related Macular Degeneration: The Challenges. In: Rakoczy, E. (eds) Gene- and Cell-Based Treatment Strategies for the Eye. Essentials in Ophthalmology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-45188-5_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-45188-5_5

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-45187-8

  • Online ISBN: 978-3-662-45188-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation